benzoxazoles has been researched along with Small Cell Lung Carcinoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fang, B; Gao, L; Guo, T; Kannan, A | 1 |
Behtaj, M; Dowlati, A; Fu, P; Kresak, A; Sakre, N; Wildey, G; Yang, M | 1 |
2 other study(ies) available for benzoxazoles and Small Cell Lung Carcinoma
Article | Year |
---|---|
Simultaneously targeting DNA damage repair pathway and mTORC1/2 results in small cell lung cancer growth arrest via ER stress-induced apoptosis.
Topics: Apoptosis; Benzoxazoles; Cell Line, Tumor; DNA Damage; Endoplasmic Reticulum Stress; Humans; Mechanistic Target of Rapamycin Complex 1; Mechanistic Target of Rapamycin Complex 2; Pyrazoles; Pyrimidines; Pyrimidinones; Small Cell Lung Carcinoma; TOR Serine-Threonine Kinases | 2018 |
RICTOR amplification identifies a subgroup in small cell lung cancer and predicts response to drugs targeting mTOR.
Topics: Adult; Aged; Aged, 80 and over; Benzamides; Benzoxazoles; Female; Fibroblast Growth Factor 10; Gene Amplification; Humans; Interleukin-7 Receptor alpha Subunit; Lung Neoplasms; Male; Middle Aged; Molecular Targeted Therapy; Morpholines; Protein Kinase Inhibitors; Pyrimidines; Rapamycin-Insensitive Companion of mTOR Protein; Small Cell Lung Carcinoma; Survival Analysis; Treatment Outcome | 2017 |